BMS-9

N/A

Report date: 2025/01/26 18:58:37
NME

Base Information

Drug NameBMS-9
Drug Alias NameBMS-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAP2-associated protein kinase 1 inhibitors
TargetsAP2-associated protein kinase 1
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb CompanyLexicon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A